Skip to main content
. 2017 Feb 6;39(3):527–538. doi: 10.3892/ijmm.2017.2880

Figure 1.

Figure 1

Isopsoralen (ISO) promotes bone-derived marrow mesenchymal stem cell (BMSC) differentiation into osteoblasts. (A) Molecular structure of ISO. (B) CCK8 assays showed that ISO did not significantly affect cell growth at the concentrations used (0.1-100 µM) following treatment for 2 days. (C–E) Alkaline phosphatase (ALP) staining showed that ISO treatment at concentrations of 5-20 µM increased ALP activity in BMSCs under osteogenic differentiation conditions for 2 weeks. *P<0.05, **P<0.01 and ***P<0.001 compared to the group without ISO (Con, control). Columns represent the means ± SD from 9 wells/group (B and E).